{"id":112296,"date":"2026-08-27T15:09:32","date_gmt":"2026-08-27T15:09:32","guid":{"rendered":"https:\/\/www.europesays.com\/britain\/112296\/"},"modified":"2026-08-27T15:09:32","modified_gmt":"2026-08-27T15:09:32","slug":"astrazeneca-prices-e2-55bn-euro-bond-sale-across-four-tranches-3","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/britain\/112296\/","title":{"rendered":"AstraZeneca prices \u20ac2.55bn euro bond sale across four tranches"},"content":{"rendered":"<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/b94feffd8d91df235ef9e23af93bb1c0cf3153d355af7e7cb5c7b1c49a6a8d41\/lightyear_networkapi\/resizefit_w960%3Bquality_80%3Bformat_webp\/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fproactive_uk_164%2F719fac2dad1163b59a57fcf651bd88b1.jpg\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"AstraZeneca prices \u20ac2.55bn euro bond sale across four tranches\" height=\"540\" width=\"960\" class=\"yf-1f8hkhu loader\"\/><\/a> AstraZeneca prices \u20ac2.55bn euro bond sale across four tranches Proactive uses images sourced from Shutterstock           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><a href=\"https:\/\/finance.yahoo.com\/quote\/AZN.l\" data-ylk=\"slk:AstraZeneca%20PLC%20(LSE%3AAZN%2C%20NASDAQ%3AAZN);elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;AstraZeneca PLC (LSE:AZN, NASDAQ:AZN)&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"nofollow noopener\">AstraZeneca PLC (LSE:AZN, NASDAQ:AZN)<\/a>, the FTSE 100 pharma group, has priced a \u20ac2.55 billion bond offering, tapping the euro debt market for general corporate purposes.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The notes were issued on Monday by AstraZeneca Finance LLC, a wholly owned US subsidiary, and carry a full and unconditional guarantee from the parent company.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The sale was split across four fixed rate tranches with maturities stretching from 2030 to 2038. The largest is a \u20ac750 million tranche maturing on 1 September 2038 with a coupon of 4.169%.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">A \u20ac700 million tranche maturing in March 2030 pays 3.402%, the cheapest money in the deal. The remaining two tranches comprise \u20ac600 million maturing in 2032 at 3.652% and \u20ac500 million maturing in 2035 at 3.923%.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The pricing curve reflects the standard pattern of investors demanding higher returns for lending over longer periods.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">AstraZeneca described the issuance as consistent with its long-term funding strategy and said proceeds would go towards general corporate purposes rather than any specific project or acquisition.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The company has been an active borrower in recent years as it funds an expanding pipeline and a series of manufacturing commitments, including substantial investment in the United States.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The notes are being issued under the euro medium-term\u00a0note programme, a standing framework that allows a company to issue debt repeatedly without drafting fresh documentation each time.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">They will be listed on the Financial Conduct Authority&#8217;s Official List and admitted to trading on the London Stock Exchange&#8217;s main market.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Barclays, Goldman Sachs International and <a href=\"https:\/\/finance.yahoo.com\/quote\/MS\" data-ylk=\"slk:Morgan%20Stanley%20(NYSE%3AMS);elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Morgan Stanley (NYSE:MS)&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"nofollow noopener\">Morgan Stanley (NYSE:MS)<\/a> acted as joint book-running managers.  <\/p>\n","protected":false},"excerpt":{"rendered":"AstraZeneca prices \u20ac2.55bn euro bond sale across four tranches Proactive uses images sourced from Shutterstock AstraZeneca PLC (LSE:AZN,&hellip;\n","protected":false},"author":2,"featured_media":112297,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20662],"tags":[11153,46174],"class_list":["post-112296","post","type-post","status-publish","format-standard","has-post-thumbnail","category-astrazeneca","tag-astrazeneca","tag-euro-debt-market"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/117168109348616797","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/112296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=112296"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/112296\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/112297"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=112296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=112296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=112296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}